JP2022533011A5 - - Google Patents
Info
- Publication number
- JP2022533011A5 JP2022533011A5 JP2021564303A JP2021564303A JP2022533011A5 JP 2022533011 A5 JP2022533011 A5 JP 2022533011A5 JP 2021564303 A JP2021564303 A JP 2021564303A JP 2021564303 A JP2021564303 A JP 2021564303A JP 2022533011 A5 JP2022533011 A5 JP 2022533011A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cognitive impairment
- gnrh
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305550.6 | 2019-04-30 | ||
| EP19305550 | 2019-04-30 | ||
| PCT/EP2020/061943 WO2020221821A1 (en) | 2019-04-30 | 2020-04-29 | Pulsative gnrh administration for treating cognitive disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533011A JP2022533011A (ja) | 2022-07-21 |
| JP2022533011A5 true JP2022533011A5 (https=) | 2023-05-11 |
| JP7779739B2 JP7779739B2 (ja) | 2025-12-03 |
Family
ID=66625872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564303A Active JP7779739B2 (ja) | 2019-04-30 | 2020-04-29 | 認知障害を処置するためのパルス状ｇｎｒｈ投与 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220202895A1 (https=) |
| EP (1) | EP3962494B1 (https=) |
| JP (1) | JP7779739B2 (https=) |
| DK (1) | DK3962494T3 (https=) |
| WO (1) | WO2020221821A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022136417A1 (en) | 2020-12-22 | 2022-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pulsative gnrh administration for treating food intake related disorders |
| WO2024047115A1 (en) | 2022-09-02 | 2024-03-07 | Leibniz-Institut Für Immuntherapie (Lit) | THERAPEUTIC USE OF THE miR155 SNP rs377265631 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3474412D1 (en) | 1984-04-14 | 1988-11-10 | Ferring Biotechnik | Device for the intermittent delivery of medicaments |
| US5013293A (en) | 1987-05-28 | 1991-05-07 | Drug Delivery Systems Inc. | Pulsating transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| US20080171736A1 (en) * | 2004-12-23 | 2008-07-17 | Gregory Christopher W | Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists |
| WO2007041386A2 (en) | 2005-09-30 | 2007-04-12 | Vyteris, Inc. | Pulsatile delivery of gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch |
| WO2014110549A1 (en) * | 2013-01-14 | 2014-07-17 | The General Hospital Corporation | Methods and assays relating to rnf216 |
| WO2014179139A2 (en) | 2013-04-30 | 2014-11-06 | Albert Einstein College Of Medicine Of Yeshiva University | TREATMENT OF AGING EFFECTS BY GONADOTROPIN-RELEASING HORMONE, NEUROGENESIS OR BRAIN IKK-β/NF-κΒ INHIBITION |
| WO2017182580A1 (en) | 2016-04-20 | 2017-10-26 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the diagnosis and the treatment of reproduction-related disorders and methods for contraception |
| CN108837143B (zh) * | 2018-09-29 | 2022-03-01 | 南华大学 | 曲普瑞林的应用 |
-
2020
- 2020-04-29 DK DK20722577.2T patent/DK3962494T3/da active
- 2020-04-29 US US17/607,676 patent/US20220202895A1/en active Pending
- 2020-04-29 WO PCT/EP2020/061943 patent/WO2020221821A1/en not_active Ceased
- 2020-04-29 EP EP20722577.2A patent/EP3962494B1/en active Active
- 2020-04-29 JP JP2021564303A patent/JP7779739B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017057230A5 (https=) | ||
| CL2021001810A1 (es) | Combinación de dextrometorfano y bupropión para el tratamiento de depresión | |
| JP2015038149A5 (https=) | ||
| JP2017506624A5 (https=) | ||
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| JP2015522630A5 (https=) | ||
| JP2014198723A5 (https=) | ||
| CN115666626A (zh) | 一种治疗阿尔茨海默病的方法和药物 | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| JP2022533011A5 (https=) | ||
| JP2022531251A5 (https=) | ||
| CN115697386A (zh) | 一种治疗帕金森病的方法和药物 | |
| JP2022551691A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| MX390101B (es) | Tratamiento medico que comprende administracion enteral de edaravona | |
| JP2019507786A5 (https=) | ||
| JP2009500045A5 (https=) | ||
| EP4389218A3 (en) | Composition for treating joint disease and kit containing same | |
| JP2023531930A5 (https=) | ||
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| JP2021530568A5 (https=) | ||
| JP2015515971A5 (https=) | ||
| MX387961B (es) | Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson. | |
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder |